guanabenz and doxazosin

guanabenz has been researched along with doxazosin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, Y; Dong, Z; Golczak, M; Maeda, A; Maeda, T; Mustafi, D; Palczewska, G; Palczewski, K; Sawada, O1
Li, T; Luo, X; She, X; Sun, X; Wang, F; Yan, Q; Yang, S; Zhang, P; Zhu, H1

Other Studies

3 other study(ies) available for guanabenz and doxazosin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.
    The Journal of clinical investigation, 2013, Volume: 123, Issue:12

    Topics: Adenine; Adenylyl Cyclase Inhibitors; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alcohol Oxidoreductases; Animals; ATP-Binding Cassette Transporters; Cell Survival; Disease Models, Animal; Doxazosin; Drug Evaluation, Preclinical; Guanabenz; Humans; Light; Macaca fascicularis; Macular Degeneration; Mice; Mice, Inbred BALB C; Mice, Knockout; Molecular Targeted Therapy; Nerve Tissue Proteins; Photoreceptor Cells, Vertebrate; Reactive Oxygen Species; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-2; Receptors, G-Protein-Coupled; Serotonin Antagonists; Signal Transduction; Stargardt Disease

2013
Modulation of α-adrenoceptor signalling protects photoreceptors after retinal detachment by inhibiting oxidative stress and inflammation.
    British journal of pharmacology, 2019, Volume: 176, Issue:6

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Animals; Apoptosis; Disease Models, Animal; Doxazosin; Guanabenz; Hyaluronic Acid; Inflammation; Injections, Intraperitoneal; Male; Oxidative Stress; Photoreceptor Cells; Protective Agents; Rats; Rats, Inbred BN; Receptors, Adrenergic, alpha-1; Signal Transduction

2019